Marinus Pharmaceuticals to Host Investor and Analyst Day on Friday, September 20, 2024
19 Août 2024 - 2:00PM
Business Wire
Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical
company dedicated to the development of innovative therapeutics to
treat seizure disorders, will host an Investor and Analyst Day on
Friday, September 20 from 9:00 a.m. to 12:00 p.m. Eastern Time in
New York and via webcast.
The event will feature presentations from Marinus management and
key opinion leaders with a focus on the Company’s development
program for ZTALMY® (ganaxolone) oral suspension CV in tuberous
sclerosis complex (TSC) ahead of the Phase 3 TrustTSC trial data
readout anticipated in the first half of the fourth quarter of
2024.
In-person attendance is open to invited research analysts and
institutional investors. All others are invited to watch the live
video webcast. Live questions will be taken by in-person guests,
and virtual participants may submit questions through the webcast
platform.
To register for the video webcast, please visit the Investor
Relations section of the Company's website at
https://ir.marinuspharma.com/events-and-presentations/. A replay of
the webcast will be archived on the Investor Relations section of
the Company's website following the event.
About Marinus Pharmaceuticals Marinus is a
commercial-stage pharmaceutical company dedicated to the
development of innovative therapeutics for seizure disorders. The
Company’s product, ZTALMY® (ganaxolone) oral suspension CV, is an
FDA-approved prescription medication introduced in the U.S. in
2022. For more information, please visit www.marinuspharma.com and
follow us on Facebook, LinkedIn and X.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240819826403/en/
Investors Sonya Weigle Chief People
and Investor Relations Officer Marinus Pharmaceuticals, Inc.
sweigle@marinuspharma.com
Media Molly Cameron Director,
Corporate Communications & Investor Relations Marinus
Pharmaceuticals, Inc. mcameron@marinuspharma.com
Marinus Pharmaceuticals (NASDAQ:MRNS)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024
Marinus Pharmaceuticals (NASDAQ:MRNS)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024
